[go: up one dir, main page]

Kretzschmar, 2003 - Google Patents

Diagnosis of prion diseases

Kretzschmar, 2003

Document ID
6966030571590140927
Author
Kretzschmar H
Publication year
Publication venue
Clinics in laboratory medicine

External Links

Snippet

The recognition and diagnosis of clinical and neuropathologic variants of human prion diseases have improved considerably after the appearance of BSE, which is now thought to be transmissible to humans and to cause variant Creutzfeldt-Jakob disease (vCJD)[1, 2] …
Continue reading at www.labmed.theclinics.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light

Similar Documents

Publication Publication Date Title
Orrú et al. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease
Bagyinszky et al. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases
Tee et al. Prion diseases
Soto Diagnosing prion diseases: needs, challenges and hopes
Cali et al. Classification of sporadic Creutzfeldt–Jakob disease revisited
Bieschke et al. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets
Kübler et al. Diagnosis of prion diseases
Teunissen et al. Brain‐specific fatty acid‐binding protein is elevated in serum of patients with dementia‐related diseases
Moda et al. MM2‐Thalamic Creutzfeldt–Jakob Disease: Neuropathological, Biochemical and Transmission Studies Identify a Distinctive Prion Strain
Ingrosso et al. Molecular diagnostics of transmissible spongiform encephalopathies
Ascari et al. Challenges and advances in antemortem diagnosis of human transmissible spongiform encephalopathies
Kim et al. Clinical update of Jakob–Creutzfeldt disease
Hyman All the tau we cannot see
Thackray et al. Evidence for co-infection of ovine prion strains in classical scrapie isolates
Condello et al. Aβ and tau prions feature in the neuropathogenesis of Down syndrome
Polymenidou et al. Atypical prion protein conformation in familial prion disease with PRNP P105T mutation
Nuvolone et al. Cystatin F is a biomarker of prion pathogenesis in mice
Rahimi et al. Non-fibrillar amyloidogenic protein assemblies-common cytotoxins underlying degenerative diseases
Keller et al. The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions
Di Fede et al. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene
Hayashi et al. An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay
Quadrio et al. Molecular diagnosis of human prion disease
Iwasaki et al. Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease
Sweeney et al. Molecular analysis of Irish sheep scrapie cases
Monaco et al. Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease with the P102L mutation